Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T18:55:38.541Z.
Calculation as of: 2026-10-06T18:55:38.541Z.
Quote observation: 2026-10-06T18:55:18.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 236ecad6846b0cc00793ea2ceb9f38c60eee5e96b58175726d9ae7432cdeb63e
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Market Cap
$669.77M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$663.94M
Price/OCF Ratio
14.39
TTM Avg
11.83
3Y Avg
25.95
5Y Avg
25.95
Market Cap
$656.86M
Price/OCF Ratio
2002.62
TTM Avg
1890.32
3Y Avg
1890.32
5Y Avg
1890.32
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Annexon, Inc. (ANNX) | $672.57M | N/A | N/A | N/A | N/A |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $669.77M | N/A | N/A | N/A | N/A |
| Helus Pharma Inc. (HELP)vs › | $670.43M | N/A | N/A | N/A | N/A |
| ArriVent BioPharma, Inc. (AVBP)vs › | $677.67M | N/A | N/A | N/A | N/A |
| MiMedx Group, Inc. (MDXG)vs › | $663.94M | 14.39 | 11.83 | 25.95 | 25.95 |
| Solid Biosciences Inc. (SLDB)vs › | $684.45M | N/A | N/A | N/A | N/A |
| Starling Oncology, Inc. (STLN)vs › | $656.86M | 2002.62 | 1890.32 | 1890.32 | 1890.32 |
| Verastem, Inc. (VSTM)vs › | $687.69M | N/A | N/A | N/A | N/A |
| Wave Life Sciences Ltd. (WVE)vs › | $691.64M | N/A | N/A | N/A | N/A |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $694.41M | N/A | N/A | N/A | N/A |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
